The facial and body care products include a night cream, a daytime sunblock and moisturizer, an an anti-cellulite and body firming cream and a day cream priced, all priced between $35 and $99 to give the new products a premium positioning on the market.
The company said that each of the new launches has been developed to follow its focus on producing formulas that give consumers a safe and effective means of 'rejuvinating aging and damaged skin'.
Currently Janson Beckett distributes its products using 300 distributors worldwide, and has already established a strong consumer base in Europe, particularly in the UK, where its organic baby care product have proved a success.
Of the new launches, the Night Cream is said to contain a high level concentration of Alpha Lipoic Acid, Vitamin C Ester and DMAE - combination that is claimed to provide one of skincare's morst provien treatments for repairing free radical damage and skin firming.
It also contains Soy Liposome with a time-released delivery system that controls absorption rate at an optimum rate for the skin.
With this complex and expensive range of ingredients, the Night Cream comes with a high-end price tag of $99 for 4oz, which means it will nestle alongside some of the most expensive anti-aging treatments on the market.
The other particularly interesting new launch is the company's Profile anti-cellulite and body cream, which claims to smooth and tone skin that by aiding circulation.
Retailing at $35, it contains Regu-Slim, which has been developed by the company Pentapharm and is said to stimulate fat-burning and promote slimming and smoothing of cellulite areas, as well as methyly nicitanate to promote 'vasodilation', which in turn helps to increase circulation of the skin, as well as a caffeine-based astringent to provide tightening and fluid reduction.
"Developing this group of products demonstrates the scope of our expertise in skincare," noted Ian Strassler, president of Janson Beckett Cosmeceuticals.
He added that the new products would serve to complement the company's existing range of peptide-based anti-aging products, which have proved to be big sellers, particularly on the US market.